Leigha Senter
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
191
Citations
10,589
Est. group size
~13
Recurring co-author estimate
Active years
21
Publishing since 2006
Leigha Senter's research focuses on hereditary cancer risk, particularly inherited mutations in genes like BRCA1, BRCA2, PMS2, and BAP1 that increase susceptibility to breast, ovarian, and colorectal cancers. This work spans clinical studies on cancer risk estimation, screening and prevention strategies (such as MRI surveillance and risk-reducing surgery), and genetic counseling approaches to help patients and families understand and manage their cancer risk. Much of the research involves large collaborative consortia and randomized trials evaluating how genetic information is communicated and used in clinical care.
Publication output was steady at 11-16 papers per year from 2017-2023 but has declined notably since 2024, though a partial rebound appears in 2026 data.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>
Journal of Clinical Oncology · 2026
- P510: Genetic counseling uptake and reasons for decline after receipt of positive CDCT1 test results in a population health setting
Genetics in Medicine Open · 2026
- Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndrome
Familial Cancer · 2026
- Lynch Syndrome in the General Population: Clinical Phenotype of <i>PMS2</i> Pathogenic Variants
JCO oncology advances. · 2026
- The Clinical Application of Refined Risk Estimates Study in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers: A Randomized Controlled Trial
Cancer Prevention Research · 2026
- BRCAShare: a video-based message can increase sharing of familial genetic test results
Hereditary Cancer in Clinical Practice · 2026
- Knowledge of cancer genetics and attitudes about genetic counseling and testing: a randomized trial of the Know Your Risk intervention compared to conventional genetic counseling
Cancer Causes & Control · 2026
- Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study
BMC Cancer · 2025
- MRI Surveillance and Breast Cancer Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
JAMA Oncology · 2024
- Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement
Gynecologic Oncology · 2024
- How Should I Counsel Patients and Families Regarding Screening Colonoscopy When There Is a Family History of Early Colorectal Cancer?
2024
- Germline and Somatic Testing for Ovarian Cancer: An SGO Clinical Practice Statement
Obstetrical & Gynecological Survey · 2024
- Germline Variants of Uncertain Significance in Gynecologic Oncology Patients
Clinical Obstetrics & Gynecology · 2024
- Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
British Journal of Cancer · 2023
- Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention
Contemporary Clinical Trials · 2023
- Gynecologic Oncology×17
- Figshare×12
- Journal of Genetic Counseling×7
- Journal of Clinical Oncology×6
- Cancer Research×5
- Na Li
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kate Shane-Carson
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Amanda Ewart Toland
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Amanda E. Toland
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Amber M. Aeilts
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile